BICYCLIC AND TRICYCLIC COMPOUNDS AS KAT II INHIBITORS
申请人:Pfizer Inc.
公开号:EP2443092A1
公开(公告)日:2012-04-25
US4375550A
申请人:——
公开号:US4375550A
公开(公告)日:1983-03-01
[EN] BICYCLIC AND TRICYCLIC COMPOUNDS AS KAT II INHIBITORS<br/>[FR] COMPOSES BICYCLIQUES ET TRICYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE KAT II
申请人:PFIZER
公开号:WO2010146488A1
公开(公告)日:2010-12-23
Compounds of Formula X: wherein A, X, Y, Z, R5, R6a, and R6b are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegenerative and/or neurological disorders in mammals, including humans.
Dadswell; Kenner, Journal of the Chemical Society, 1927, p. 1106
作者:Dadswell、Kenner
DOI:——
日期:——
Synthesis and reactions of some cyclohexadienones. Part II
作者:J. R. Merchant、V. B. Desai
DOI:10.1039/j39680000499
日期:——
The synthesis of 4-alkyl-4-trihalogenomethylcyclohexa-2,5-dienone derivatives by the application of the Zincke–Suhl reaction on p-alkyl-phenols is described. In some cases, only benzophenone derivatives were obtained. When the dienones were treated with reagents like phosphorus pentachloride and sulphuric acid, migration of the groups from the gem-C-atom occurred giving rise to halogenated benzoic